Suppr超能文献

低密度脂蛋白对系膜细胞纤连蛋白合成的刺激作用:蛋白激酶C和转化生长因子-β的作用

Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-beta.

作者信息

Studer R K, Craven P A, DeRubertis F R

机构信息

Veterans Affairs Medical Center, Pittsburgh, PA 15240.

出版信息

J Lab Clin Med. 1995 Jan;125(1):86-95.

PMID:7822950
Abstract

Low-density lipoprotein (LDL) cholesterol has been implicated in the pathogenesis of glomerulosclerosis in diabetes and other forms of glomerular injury. In the present study we evaluated the effect of LDL on fibronectin synthesis in cultured rat mesangial cells (MCs) and the roles of protein kinase C (PKC) and transforming growth factor-beta (TGF-beta) in mediating this LDL action. In MCs, 25 micrograms to 100 micrograms/ml LDL increased PKC activity within 15 minutes, as reflected by enhanced in situ phosphorylation of the 80 kd myristoylated alanine-rich C kinase substrate protein, a specific endogenous substrate of PKC in MC. The same concentrations of LDL subsequently (18 to 72 hours) enhanced fibronectin synthesis, as reflected by increased incorporation of labeled methionine into fibronectin. GF 109203X, a selective inhibitor of PKC, blocked increases in both PKC activity and fibronectin synthesis induced by LDL in MCs. Furthermore, prior downregulation of PKC to less than 1% of basal activity by exposure of MCs to 0.5 mumol/L phorbol myristate acetate (PMA) also prevented LDL stimulation of fibronectin synthesis. The activation of PKC by LDL seen after 15 minutes of exposure was transient and was not observed after 4 or 48 hours of exposure of MCs to LDL. However, exposure to LDL for 48 hours, but not for 15 minutes or 4 hours, increased both maximal PKC responses to phorbol dibutyrate (PDBu) and tritiated PDBu binding to MCs by 30%. These findings suggest that chronic exposure to LDL increases the total PKC content in MCs and thereby might modulate responses to other PKC agonists. Neither the cyclooxygenase inhibitor piroxicam nor the thromboxane/prostaglandin endoperoxide receptor blocker Sq-29548 altered LDL stimulation of fibronectin synthesis in MCs, suggesting that this action of LDL was not mediated by changes in MC eicosanoid generation. By contrast, antibody to TGF-beta blocked LDL stimulation of fibronectin synthesis in MCs. TGF-beta bioactivity, determined with the mink lung epithelial cell assay, was two to three times higher in the medium of MCs cultured with LDL for 24 to 48 hours as compared with corresponding control values. Total TGF-beta bioactivity examined after heat activation of latent TGF-beta was also two times higher in the medium of MCs exposed to LDL as compared with that of controls. Prior down-regulation of PKC by exposure of MCs to PMA blocked the increases in TGF-beta bioactivity induced by LDL.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

低密度脂蛋白(LDL)胆固醇与糖尿病及其他形式肾小球损伤所致的肾小球硬化发病机制有关。在本研究中,我们评估了LDL对培养的大鼠系膜细胞(MCs)中纤连蛋白合成的影响,以及蛋白激酶C(PKC)和转化生长因子-β(TGF-β)在介导LDL这一作用中的角色。在MCs中,25微克至100微克/毫升的LDL在15分钟内增加了PKC活性,这可通过80kd富含肉豆蔻酰化丙氨酸的C激酶底物蛋白的原位磷酸化增强得以体现,该蛋白是MC中PKC的一种特异性内源性底物。相同浓度的LDL随后(18至72小时)增强了纤连蛋白的合成,这可通过标记的甲硫氨酸掺入纤连蛋白增加得以反映。GF 109203X是一种PKC的选择性抑制剂,可阻断LDL诱导的MCs中PKC活性和纤连蛋白合成的增加。此外,通过将MCs暴露于0.5微摩尔/升佛波酯肉豆蔻酸酯(PMA)使PKC预先下调至基础活性的1%以下,也可防止LDL对纤连蛋白合成的刺激。暴露于LDL 15分钟后可见的LDL对PKC的激活是短暂的,在MCs暴露于LDL 4小时或48小时后未观察到这种激活。然而,将MCs暴露于LDL 48小时而非15分钟或4小时,可使对佛波酯二丁酯(PDBu)的最大PKC反应以及氚标记的PDBu与MCs的结合增加30%。这些发现表明,长期暴露于LDL会增加MCs中PKC的总量,从而可能调节对其他PKC激动剂的反应。环氧合酶抑制剂吡罗昔康和血栓素/前列腺素内过氧化物受体阻滞剂Sq-29548均未改变LDL对MCs中纤连蛋白合成的刺激,这表明LDL的这一作用不是由MC类花生酸生成的变化介导的。相比之下,抗TGF-β抗体可阻断LDL对MCs中纤连蛋白合成的刺激。用貂肺上皮细胞试验测定的TGF-β生物活性,在与LDL一起培养24至48小时的MCs培养基中比相应的对照值高两到三倍。在潜伏性TGF-β热激活后检测的总TGF-β生物活性,在暴露于LDL的MCs培养基中也比对照高两倍。通过将MCs暴露于PMA预先下调PKC可阻断LDL诱导的TGF-β生物活性增加。(摘要截短于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验